International Health
Volume 1, Issue 2 , Pages 182-189, December 2009

Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods

  • Elizabeth A. Cromwell

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
  • ,
  • Jeremiah Ngondi

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, UK
  • ,
  • Gideon Gatpan

      Affiliations

    • The Carter Center, Munuki Industrial Area, Juba, Southern Sudan
  • ,
  • Steven Becknell

      Affiliations

    • The Carter Center, Munuki Industrial Area, Juba, Southern Sudan
  • ,
  • Lucia Kur

      Affiliations

    • Ministry of Health, Government of Southern Sudan, Juba, Southern Sudan
  • ,
  • Deborah McFarland

      Affiliations

    • Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
  • ,
  • Jonathan D. King

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
  • ,
  • Paul M. Emerson

      Affiliations

    • The Carter Center, 1 Copenhill Avenue, Atlanta, Georgia, USA
    • Corresponding Author InformationCorresponding author.

Received 15 July 2009; received in revised form 24 August 2009; accepted 3 September 2009.

Summary 

Trachoma control includes mass drug administration (MDA) with antibiotics targeting coverage of at least 80%. Coverage is traditionally calculated by dividing doses distributed by population estimate, which is unreliable. We compared a verifiable coverage assessment method against self-reported participation and the traditional calculation, and examined factors associated with MDA participation in Akobo County, Southern Sudan. During MDA, recipients were marked with indelible ink and followed-up using a two-stage household survey: 25 clusters from three districts, and 10 households per cluster. All household members were enumerated; asked about self-reported participation and observed for indelible marks. Household heads were interviewed to assess factors associated with MDA. Overall 11 419 treatments were given and 1358 residents from 247 households surveyed. By traditional methods MDA coverage was 20.9% (95% CI: 20.6-21.3); 61.5% (95 % CI: 49.4-73.6) by self-reporting; and 37.5% (95% CI: 25.1%-49.9%) from observed ink marks. Controlling for other factors, presence of a health worker (OR 2.3, 95% CI: 1.5-3.6); head of household knowledge of azithromycin (OR 1.6, 95% CI: 1.5-3.1); and head of household advance notice of MDA (OR 34.9, 18.1-66.3) were independent predictors of participation. Cluster randomised surveys can estimate MDA coverage better than the traditional method and implementation of indelible marking merits investigation.

Keywords: Coverage survey, mass drug administration, population coverage, SAFE strategy, Southern Sudan, trachoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1876-3413(09)00039-4

doi:10.1016/j.inhe.2009.09.002

International Health
Volume 1, Issue 2 , Pages 182-189, December 2009